Top five refractive surgery items from 2022
Click Here to Manage Email Alerts
This year’s top refractive surgery item was the announcement about the FDA approval of the STAAR Surgical EVO/EVO+ Visian ICL to treat myopia and myopia with astigmatism, complete with physician perspectives.
Read about this and other top refractive surgery stories from 2022 below.
Source: Adobe Stock.
FDA approves EVO Visian lens
A preoperative peripheral iridotomy, which was required with earlier versions of the Visian ICL, is not needed with the EVO. Read more.
Certain patients may be better suited for presbyopia drops
More options are on the way to treat patients with presbyopia, according to a presentation at Real World Ophthalmology. Read more.
Nyxol meets endpoint in phase 3 night vision disturbance trial
Nyxol from Ocuphire Pharma demonstrated positive topline results in subjects with night vision disturbances in the phase 3 LYNX-1 pivotal clinical trial. Read more.
VIDEO: Future of refractive surgery will bring new techniques, increased demand
NEW YORK — Eric D. Donnenfeld, MD, provides insight on what surgeons should expect the future of refractive surgery to look like and addresses the uncertainties of industry changes to come in a presentation at OSN New York. Watch here.
Laser vision correction procedures up 32% in fourth quarter 2021
Laser vision correction procedures totaled 190,509 in the fourth quarter of 2021, marking a 32% year-to-date increase over 2020, according to a press release from the Refractive Surgery Council. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts